698 related articles for article (PubMed ID: 12905467)
21. [IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis].
Naranjo Hernández A; Muniain Ezcurra MA; Vargas Lebrón MC; Rodríguez Barrera JM; Prieto Martínez J; Navarro Sarabia F
An Med Interna; 1989 Nov; 6(11):575-9. PubMed ID: 2562699
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.
De Vita S; Zaja F; Sacco S; De Candia A; Fanin R; Ferraccioli G
Arthritis Rheum; 2002 Aug; 46(8):2029-33. PubMed ID: 12209504
[TBL] [Abstract][Full Text] [Related]
23. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.
Bobbio-Pallavicini F; Alpini C; Caporali R; Avalle S; Bugatti S; Montecucco C
Arthritis Res Ther; 2004; 6(3):R264-72. PubMed ID: 15142273
[TBL] [Abstract][Full Text] [Related]
25. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study.
Sellam J; Hendel-Chavez H; Rouanet S; Abbed K; Combe B; Le Loët X; Tebib J; Sibilia J; Taoufik Y; Dougados M; Mariette X
Arthritis Rheum; 2011 Apr; 63(4):933-8. PubMed ID: 21225699
[TBL] [Abstract][Full Text] [Related]
26. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
García-Berrocal B; González C; Pérez M; Navajo JA; Moreta I; Dávila C; González-Buitrago JM
Clin Chim Acta; 2005 Apr; 354(1-2):123-30. PubMed ID: 15748608
[TBL] [Abstract][Full Text] [Related]
27. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
28. Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics.
De La Torre I; Leandro MJ; Valor L; Becerra E; Edwards JC; Cambridge G
Rheumatology (Oxford); 2012 May; 51(5):833-40. PubMed ID: 22253030
[TBL] [Abstract][Full Text] [Related]
29. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
Cambridge G; Perry HC; Nogueira L; Serre G; Parsons HM; De La Torre I; Dickson MC; Leandro MJ; Edwards JC
J Autoimmun; 2014 May; 50():67-76. PubMed ID: 24365380
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of the relation between serum immunoglobulin and auto-antibody levels in patients with rheumatoid arthritis].
Liu F; Wang Q; Qiu YR; Li MM
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):472-3, 476. PubMed ID: 12754134
[TBL] [Abstract][Full Text] [Related]
31. Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion.
Váncsa A; Szabó Z; Szamosi S; Bodnár N; Végh E; Gergely L; Szucs G; Szántó S; Szekanecz Z
J Rheumatol; 2013 May; 40(5):565-71. PubMed ID: 23547216
[TBL] [Abstract][Full Text] [Related]
32. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
33. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
[TBL] [Abstract][Full Text] [Related]
34. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
35. Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
Ahmed MM; Mubashir E; Wolf RE; Hayat S; Hall V; Shi R; Berney SM
South Med J; 2006 Nov; 99(11):1209-15. PubMed ID: 17195414
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
Higashida J; Wun T; Schmidt S; Naguwa SM; Tuscano JM
J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
[TBL] [Abstract][Full Text] [Related]
37. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.
Nielen MM; van Schaardenburg D; Reesink HW; van de Stadt RJ; van der Horst-Bruinsma IE; de Koning MH; Habibuw MR; Vandenbroucke JP; Dijkmans BA
Arthritis Rheum; 2004 Feb; 50(2):380-6. PubMed ID: 14872479
[TBL] [Abstract][Full Text] [Related]
38. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
Roll P; Dörner T; Tony HP
Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
[TBL] [Abstract][Full Text] [Related]
39. Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis?
Lacki JK; Hrycaj P; Klama K; Mackiewicz U; Mackiewicz SH; Muller W
Mater Med Pol; 1994; 26(3):97-100. PubMed ID: 7603085
[TBL] [Abstract][Full Text] [Related]
40. Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
Szodoray P; Alex P; Dandapani V; Nakken B; Pesina J; Kim X; Wallis GL; Wilson PC; Jonsson R; Centola M
Scand J Immunol; 2004; 60(1-2):209-18. PubMed ID: 15238091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
